Top Pharmaceuticals companies in Sweden by Total Liabilities

This ranking features the top 38 Pharmaceuticals companies in Sweden ranked by Total Liabilities, totaling a Total Liabilities of USD 3.83 B, for July 04, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Pharmaceuticals company in Sweden has the highest Total Liabilities ?

The Pharmaceuticals company in Sweden with the highest Total Liabilities is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 3.16 B.

Which Pharmaceuticals company in Sweden has the lowest Total Liabilities ?

The Pharmaceuticals company in Sweden with the lowest Total Liabilities is Carbiotix AB (Stockholm Stock Exchange: CRBX.ST) at None.

What are the top 10 Pharmaceuticals companies in Sweden by Total Liabilities ?

The top 10 Pharmaceuticals companies in Sweden by Total Liabilities are Swedish Orphan Biovitrum AB (publ), Vimian Group AB (publ), Orexo AB (publ), Magle Chemoswed Holding AB (publ), Camurus AB (publ), BioGaia AB (publ), Egetis Therapeutics AB (publ), Xspray Pharma AB (publ), Devyser Diagnostics AB (publ) and SynAct Pharma AB.

What are the bottom 10 Pharmaceuticals companies in Sweden by Total Liabilities ?

The bottom 10 Pharmaceuticals companies in Sweden by Total Liabilities are Carbiotix AB, Chordate Medical Holding AB (publ), BioArctic AB (publ), BrainCool AB (publ), Aptahem AB (publ), Alzinova AB (publ), aXichem AB, AlzeCure Pharma AB (publ), BioInvent International AB (publ) and Diamyd Medical AB (publ).